Tobias Cohen - Search Results

Year	Number of Results
2010	2
2012	1
2013	1
2014	1
2015	1
2016	2
2020	1
2021	2
2024	0

1

Granulocyte Transfusion: Clinical Updates and a Practical Approach to Transfusion.

Cohen T, Simmons SC, Pham HP, Staley EM. Cohen T, et al. Clin Lab Med. 2021 Dec;41(4):647-657. doi: 10.1016/j.cll.2021.07.007. Epub 2021 Sep 29. Clin Lab Med. 2021. PMID: 34689971 Review.

2

The strengths and weaknesses of viscoelastic testing compared to traditional coagulation testing.

Cohen T, Haas T, Cushing MM. Cohen T, et al. Transfusion. 2020 Oct;60 Suppl 6:S21-S28. doi: 10.1111/trf.16073. Transfusion. 2020. PMID: 33089934 Review.

3

Valspodar limits human cytomegalovirus infection and dissemination.

Parsons AJ, Cohen T, Schwarz TM, Stein KR, Ophir SI, Casado JP, Tortorella D. Parsons AJ, et al. Among authors: cohen t. Antiviral Res. 2021 Sep;193:105124. doi: 10.1016/j.antiviral.2021.105124. Epub 2021 Jun 28. Antiviral Res. 2021. PMID: 34197862 Free PMC article.

4

The Microtubule Inhibitor Podofilox Inhibits an Early Entry Step of Human Cytomegalovirus.

Cohen T, Schwarz TM, Vigant F, Gardner TJ, Hernandez RE, Lee B, Tortorella D. Cohen T, et al. Viruses. 2016 Oct 24;8(10):295. doi: 10.3390/v8100295. Viruses. 2016. PMID: 27783035 Free PMC article.

5

Convallatoxin-Induced Reduction of Methionine Import Effectively Inhibits Human Cytomegalovirus Infection and Replication.

Cohen T, Williams JD, Opperman TJ, Sanchez R, Lurain NS, Tortorella D. Cohen T, et al. J Virol. 2016 Nov 14;90(23):10715-10727. doi: 10.1128/JVI.01050-16. Print 2016 Dec 1. J Virol. 2016. PMID: 27654292 Free PMC article.

6

Predictors of squamous cell carcinoma in high-risk patients in the VATTC trial.

Xiong MY, Rizzo AE, Cohen TS, Dyer RK, Korgavkar K, Bingham SF, Weinstock MA; Veterans Affairs Topical Tretinoin Chemoprevention(VATTC) Trial Group. Xiong MY, et al. Among authors: cohen ts. J Invest Dermatol. 2013 Jun;133(6):1521-32. doi: 10.1038/jid.2013.35. Epub 2013 Feb 24. J Invest Dermatol. 2013. PMID: 23348836 Free article. Clinical Trial.

7

Development of a high-content screen for the identification of inhibitors directed against the early steps of the cytomegalovirus infectious cycle.

Gardner TJ, Cohen T, Redmann V, Lau Z, Felsenfeld D, Tortorella D. Gardner TJ, et al. Among authors: cohen t. Antiviral Res. 2015 Jan;113:49-61. doi: 10.1016/j.antiviral.2014.10.011. Epub 2014 Oct 31. Antiviral Res. 2015. PMID: 25446405 Free PMC article.

8

Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial.

Dyer RK, Weinstock MA, Cohen TS, Rizzo AE, Bingham SF; VATTC Trial Group. Dyer RK, et al. Among authors: cohen ts. J Invest Dermatol. 2012 Nov;132(11):2544-51. doi: 10.1038/jid.2012.227. Epub 2012 Jul 19. J Invest Dermatol. 2012. PMID: 22810303 Free article. Clinical Trial.

9

A method for individualizing the prediction of immunogenicity of protein vaccines and biologic therapeutics: individualized T cell epitope measure (iTEM).

Cohen T, Moise L, Ardito M, Martin W, De Groot AS. Cohen T, et al. J Biomed Biotechnol. 2010;2010:961752. doi: 10.1155/2010/961752. Epub 2010 Jul 18. J Biomed Biotechnol. 2010. PMID: 20706613 Free PMC article.

10

Species neutral correlates of immunogenicity for vaccines and protein therapeutics: fact or science fiction.

De Groot AS, Baker M, Cohen T. De Groot AS, et al. Among authors: cohen t. Hum Vaccin. 2010 May;6(5):371-2. Hum Vaccin. 2010. PMID: 20551718 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

10 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year